Skip to content

Can you build a tolerance to epilepsy medication? Understanding Drug Resistance

5 min read

For approximately 30% of people with epilepsy, medications lose their effectiveness over time, raising the question: Can you build a tolerance to epilepsy medication?. This phenomenon is a form of drug resistance, where the body's adaptive changes can cause a previously effective antiseizure medication (ASM) to become less powerful, leading to a return of seizures.

Quick Summary

The loss of efficacy of antiseizure medication over time, or tolerance, is a known form of drug resistance that affects a subset of patients due to complex biological factors and adaptive changes in the body.

Key Points

  • Tolerance to ASMs is a documented phenomenon: Some patients lose effectiveness from their antiseizure medication (ASM) over time, a form of drug resistance known as tolerance.

  • The 'Honeymoon Effect' is an example of tolerance: This temporary period of seizure control followed by a return of seizures is a classic sign of developing drug tolerance.

  • Mechanisms are both pharmacokinetic and pharmacodynamic: Tolerance can arise from changes in how the body processes the drug or from adaptive changes in the brain's cellular targets.

  • Not all treatment failure is tolerance: Other factors like missed doses, disease progression, or lifestyle triggers can also cause seizures to return.

  • Specialist evaluation is crucial for management: An epilepsy specialist can help distinguish tolerance from other issues and develop a new treatment plan, which may involve dose adjustments, switching medications, or exploring alternative therapies.

  • Drug-resistant epilepsy has other treatment options: When medications fail, advanced therapies such as surgery, neuromodulation, or dietary therapies may be considered.

In This Article

What is Tolerance to Epilepsy Medication?

Tolerance to epilepsy medication, also known as antiseizure drug (ASD) tolerance, refers to the progressive reduction in a drug's effectiveness during prolonged administration. It is distinct from drug resistance, which is generally defined as the failure to achieve sustained seizure freedom after adequate trials of two or more appropriately chosen ASMs. While not a serious issue for all epilepsy patients, tolerance is a significant aspect of treatment for a subset, and it can contribute to a diagnosis of drug-resistant epilepsy. The development of tolerance can be frustrating for patients who initially experience excellent seizure control only to see their seizures gradually return over time.

The "Honeymoon Effect"

One common manifestation of tolerance is the so-called "honeymoon effect". This occurs when a patient has an initial good response to a new ASM, sometimes becoming seizure-free for weeks or months. However, over time, the seizures return to their previous frequency, or even worsen. The honeymoon effect is most often described in association with benzodiazepines, but evidence suggests it may affect many, if not all, ASMs in a subgroup of patients.

The Mechanisms Behind Drug Tolerance

The exact mechanisms driving ASD tolerance are complex and not yet fully understood, but researchers have identified several contributing factors. These mechanisms can be broadly categorized into pharmacokinetic and pharmacodynamic changes.

Pharmacokinetic Mechanisms

Pharmacokinetic tolerance relates to how the body processes and distributes the drug. It includes changes that reduce the concentration of the drug at its target site in the brain.

  • Enzyme Induction: Some ASMs, particularly older-generation drugs, can cause the liver to produce more of the enzymes that break down and metabolize the drug. Over time, this increased enzyme activity can cause the drug to be eliminated from the body more quickly, leading to a lower concentration in the blood and brain.
  • Efflux Transporters: The blood-brain barrier is equipped with proteins called efflux transporters (such as P-glycoprotein) that act as pumps, actively removing foreign substances, including ASMs, from the brain and pumping them back into the bloodstream. Increased activity or expression of these transporters over time can reduce the amount of medication reaching the brain, leading to a loss of efficacy.

Pharmacodynamic Mechanisms

Pharmacodynamic tolerance involves changes at the cellular or molecular level that reduce the effectiveness of the drug, even if drug concentrations remain stable.

  • Receptor Adaptation: Many ASMs work by targeting specific receptors or ion channels in the brain to stabilize neuronal activity. With prolonged exposure, these targets can become less sensitive to the drug's effects, or their number can decrease, a process known as receptor downregulation.
  • Adaptive Neural Networks: The epileptic brain itself may adapt to the drug's effects. The brain's neuronal networks are highly plastic and can undergo reorganization in response to persistent abnormal seizure activity. This neural plasticity may allow the brain to overcome the effects of the medication, even if the drug and its targets remain unchanged.

Other Factors Mimicking Tolerance

It is important to distinguish true tolerance from other factors that can cause a return or increase of seizures. A sudden increase in seizure activity may not be due to tolerance but could be related to other issues.

  • Poor Adherence: Skipping doses or not taking the medication as prescribed can lead to lower-than-therapeutic drug levels, causing seizures to return.
  • Drug Interactions: Other medications or supplements can interact with ASMs, altering their effectiveness.
  • Lifestyle Factors: Stress, sleep deprivation, and alcohol consumption can lower the seizure threshold and trigger seizures, regardless of medication effectiveness.
  • Disease Progression: The underlying epilepsy may simply be progressing over time, leading to worsening seizures.

Comparison of Tolerance Mechanisms

Feature Pharmacokinetic Tolerance Pharmacodynamic Tolerance
Underlying Cause Changes in how the body processes and eliminates the drug. Adaptations at the drug's target sites within the nervous system.
Mechanism Examples Increased liver enzyme activity, induction of efflux transporters at the blood-brain barrier. Downregulation or decreased sensitivity of drug-targeted receptors or ion channels.
Effect on Drug Levels Results in lower concentration of the drug reaching the brain over time. Can occur even with stable, therapeutic drug levels in the brain.
Clinical Manifestation Drug initially effective, but efficacy gradually diminishes as the body metabolizes it faster. Drug initially effective, but brain's nervous system adapts to counteract its effects, leading to a return of seizures.
Potential Management May require increasing dosage to maintain blood levels, though this has limits. Often requires changing medication or exploring alternative treatments.

How to Identify and Manage Tolerance

For patients who suspect they are developing tolerance, it is crucial to work closely with an epilepsy specialist to re-evaluate the treatment plan. Identifying tolerance is difficult due to the many factors that can influence seizure control. The specialist may first rule out other potential causes, such as missed doses, before adjusting medication.

Strategies that may be considered include:

  • Dosage Adjustment: In some cases, increasing the dosage of the current ASM can temporarily restore efficacy, although this approach can have limited and variable success, especially if the tolerance is absolute.
  • Medication Switch: Transitioning to a different ASM, ideally one with a different mechanism of action, can sometimes restore seizure control. However, this may be complicated by cross-tolerance, where tolerance to one drug affects the response to others.
  • Combination Therapy: For some patients, combining two or more ASMs with different mechanisms of action can be effective. This approach may help control seizures by targeting different pathways, though it can increase the risk of side effects.
  • Referral to an Epilepsy Center: When medication tolerance leads to drug-resistant epilepsy, a comprehensive evaluation at a specialized epilepsy center is often the next step.

Management Strategies for Drug-Resistant Epilepsy

Once a patient is diagnosed with drug-resistant epilepsy, typically after failing two or more medication trials, further options beyond medication may be explored.

  • Epilepsy Surgery: For patients with focal epilepsy (seizures originating from one specific brain area), surgery to remove the seizure focus can be a highly effective treatment option. Modern techniques, including minimally invasive laser ablation, have improved outcomes.
  • Neuromodulation Devices: For patients who are not suitable candidates for surgery, devices such as the Vagal Nerve Stimulator (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS) can help manage seizures by sending electrical signals to the brain. These are generally not curative but can significantly reduce seizure frequency.
  • Dietary Therapies: For certain types of epilepsy, particularly in children, a ketogenic diet or other specialized diets can be effective in reducing seizures.

Conclusion

While the prospect of building tolerance to an epilepsy medication can be discouraging, it is a known phenomenon that is part of the broader issue of drug resistance in epilepsy. Tolerance is not a sign of failure but an indication that the epilepsy and the patient's body have adapted to the medication over time. Understanding the distinction between tolerance and other causes of seizure recurrence is essential for effective management. With the help of an epilepsy specialist, and by exploring a range of strategies from medication adjustments to advanced therapies like surgery or neuromodulation, many patients can find a path toward better seizure control, even after experiencing tolerance. The Epilepsy Foundation offers valuable resources for those navigating this challenging journey. For more information, visit the Epilepsy Foundation website.

Frequently Asked Questions

While not all patients experience it, developing tolerance to an epilepsy medication is a recognized phenomenon, particularly in a subgroup of individuals with drug-resistant epilepsy.

The 'honeymoon effect' is when a patient initially responds well to a new medication, achieving seizure control for a period of weeks or months, only for the seizures to eventually return.

The reasons are complex and may include individual genetic factors, the specific type of epilepsy, and the drug's mechanism of action. The time course of tolerance can also differ among patients.

It is essential to contact your neurologist or epilepsy specialist. Do not stop or change your medication dosage on your own. They can determine if you are experiencing tolerance or if another factor is causing the change.

Tolerance is one of the possible mechanisms contributing to drug-resistant epilepsy, which is the broader condition defined as the failure of two or more medications to achieve seizure freedom.

Switching to a different ASM is a common strategy, but its effectiveness can vary. Sometimes, a patient may experience 'cross-tolerance,' where tolerance to one drug leads to reduced responsiveness to another.

For patients with drug-resistant epilepsy, options beyond medication include surgical removal of the seizure focus, implantable neuromodulation devices (VNS, RNS, DBS), and dietary therapies.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.